Explore company profiles, quarterly results, announcements and ownership disclosures.
Loading the company view…
Sun Pharma Advanced Research Company Limited (NSE: SPARC), ISIN INE232I01014 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
SPARC last traded at ₹205.65 (+3.88%), with a 52-week range of ₹108.20 to ₹289.00 (as of 23 Sep 2026).
Shareholding as of Jun 2026: promoters 65.67%, FIIs 3.90%, DIIs 0.09%, mutual funds 0.08%.
EquiSense Score (ECS): 59/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.